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The large scale genomewide association studies (GWAS) have identified approximately 80 single nucleotide polymorphisms (SNPs)
conferring susceptibility to type 2 diabetes (T2D). However, most of these loci have not been replicated in diverse populations and
much genetic heterogeneity has been observed across ethnic groups. We tested 28 SNPs previously found to be associated with
T2D by GWAS in a Mongolian sample of Northern China (497 diagnosed with T2D and 469 controls) for association with T2D
and diabetes related quantitative traits. We replicated T2D association of 11 SNPs, namely, rs7578326 (IRS1), rs1531343 (HMGA2),
rs8042680 (PRC1), rs7578597 (THADA), rs1333051 (CDKN2), rs6723108 (TMEM163), rs163182 and rs2237897 (KCNQ1), rs1387153
(MTNR1B), rs243021 (BCL11A), and rs10229583 (PAX4) in our sample. Further, we showed that risk allele of the strongest T2D
associated SNP in our sample, rs757832 (IRS1), is associated with increased level of TG. We observed substantial difference of
T2D risk allele frequency between the Mongolian sample and the 1000G Caucasian sample for a few SNPs, including rs6723108
(TMEM163) whose risk allele reaches near fixation in the Mongolian sample. Further study of genetic architecture of these variants
in susceptibility of T2D is needed to understand the role of these variants in heterogeneous populations.
1. Introduction
Type 2 diabetes (T2D) is a complex disease characterized
by insulin resistance and pancreatic beta-cell dysfunction. In
China, 9.7% and 15.5% of the entire population suffer from
T2D and prediabetes, respectively [1]. Given recent advances
in genotyping and sequencing technology, the GWAS have
contributed significantly to the identification of susceptibility
loci for T2D and many other complex disorders. At least
80 loci conferring susceptibility to T2D have been identi-
fied to date [2, 3] (http://www.genome.gov/gwastudies/) and
the genetic architecture underlying T2D varies substantially
between populations of different ethnic backgrounds [4, 5].
Studying genetics of T2D in multiethnic cohorts has been
insightful for fine-mapping casual variants and identifying
new loci [6], demonstrating the use of investigating common
variants in different ethnic samples.
There are 10 million Mongolians currently living in
various regions of Asia [7]. To our knowledge, there is only
one T2D association study conducted in aMongolian sample,
which replicated association of variants in KCNQ1 and
ABCC8 with T2D [8]. However, the small-sized study (177
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cases and 216 controls) has low power to detect variants with
smaller effect.The prevalence of T2D inMongolians in China
has grown among the adult urban population from 1.86% in
1980 to 5.6% in 2012 [9–11]. In our study, we aim to explore
genetic risks of 34 T2D SNPs previously reported by GWAS
in a larger Mongolian sample. Twenty-eight SNPs passed
rigorous quality control filtering and 11 of them showed
significant association with T2D (Bonferroni corrected 𝑃 <
0.05).The SNPwith the strongest T2D association, rs7578326,
has the risk allele significantly associatedwith increased levels
of TG. We demonstrated the need of further study of allelic
difference of T2D associated SNPs in diverse populations.
2. Methods and Materials
2.1. Ethics Statement. This study was approved by the Insti-
tutional Review Board of the Affiliated Hospital of Inner
Mongolia University for the Nationalities and complied with
the Declaration of Helsinki. The written informed consent
was obtained from each participant.
2.2. Study Population. We collected whole blood samples
from 986 individuals of Mongolian ethnicity from Inner
Mongolia, China.The sample was comprised of 511 T2D cases
and 475 healthy normoglycemic controls, of which 497 cases
and 469 controls passed quality control filtering and were
used for subsequent analysis (see below). Cases were regis-
tered based on the World Health Organization (WHO) cri-
teria [12] of fasting plasma glucose concentration ≥7mmol/L
or 2-h plasma glucose concentration ≥11.1mmol/L and were
admitted to the affiliated hospital of the Inner Mongolia
University for Nationalities. Nondiabetic healthy controls
were selected based on matching sex and ethnic background
from the same region. Aside from the diagnosis of T2D, we
collected other diabetes related lipid traits, such as TC, HDL-
C, LDL-C, and TG, for each individual. We collected certain
life style information (smoking and drinking habits), waist
circumference (WC), and body mass index (BMI) of each
participant as well.
2.3. Selection of SNPs and Genotyping. We selected a list
of SNPs previously found to be associated with T2D based
on the NHGRI GWAS catalog [2] (available at http://www
.genome.gov/gwastudies/, November, 2012). Candidate SNPs
were initially selected with the following considerations: (1)
SNPs found to be associated with T2D in an Asian sample
were given higher priority (rs6723108 and rs5945326 were
added after the initial selection date); and (2) subsequently
SNPs found to be associated with multiple studies were
included.Wewere able to genotype 34 SNPs located in or near
33 candidate genes (see Supplementary Material available
online at http://dx.doi.org/10.1155/2015/613236). We included
two SNPs around KCNQ1, because those have been reported
to be associated with Asian populations [13, 14].
We estimated the concentration of isolated genomicDNA
using Qubit dsDNA BR Assay Kit (Invitrogen, USA), and
the DNA solution was further diluted to a concentration
of 10 ng/𝜇L. We designed the targeted sequencing primers
and redesigned the primer sets with dispersed or weak
electrophoretic bands. To prepare the chip array, we used
a multisample nanodispenser (WaferGen, USA) to disperse
DNA and primers into SmartChip MyDesign Chip (Wafer-
Gen, USA). Following the polymerase chain reaction (PCR)
amplification, we purified PCR products through Agencourt
AMPure XP-medium beads to get mixed Illumina pair-end
libraries. Insert sizes were calculated by Aglient 2100 bio-
analyzer (Agilent, USA) and concentrations were estimated
by Real Time PCR. Sequencing was performed on either
Illumina MiSeq or on Illumina Hiseq 2500. All sequencing
steps were in strict accordance with Illumina recommended
protocols.
The final sequencing depth reached > 200x, and the
length of pair-end reads was 100 bp. Reads with an average
base quality of ≥20 were kept for further analysis. BWA
[15] (v0.5.9, available at http://bio-bwa.sourceforge.net/) was
used to map all clean reads against the human reference
genome of hg19 allowing ≤3 mismatches across a single
read. Samtools mpileup (v0.1.18, available at http://samtools
.sourceforge.net/) command was used to obtain SNP geno-
types as described in [16].
These genotypes were further filtered according to the
following criteria: SNPs with ≥5% of missing call rate across
the samples. Samples with ≥3% of missing genotypes (which
corresponds to 10% of missing SNP call rate) were removed.
We tested SNPs forHardy-Weinberg Equilibrium (HWE) and
excluded SNPs with HWE 𝑃 value < 1 × 10−6 in unaffected
individuals. Twenty-eight SNPs of 966 samples (497 cases
and 469 controls) passed the quality control filtering, and the
overall genotype call rate is 99.3%or higher across the sample.
2.4. Statistical Analysis. We tested association between can-
didate SNPs and the status of T2D using logistic regression
(likelihood ratio test) by adjusting for the effects of age, sex,
and BMI. The study-wide significance was determined by
applying Bonferroni correction using 28 tested SNPs (𝑃 value
≤ 0.05/28 = 1.8 × 10−3). We tested association with diabetes
related quantitative traits (TC, HDL-C, LDL-C, and TG)
across both T2D cases and controls using linear regression
with the age, sex, BMI, andT2D status as covariates. All quan-
titative trait measures were normalized by quantile normal-
ization and the normalized values were used in the analyses.
Formal statistical tests, including 95% confidence intervals
(CI), were performed using EPACTS [17] (v3.2.6, avail-
able at http://www.sph.umich.edu/csg/kang/epacts/). Dif-
ferences in population structure between the Mongolian
sample (healthy controls) and healthy Caucasian (CEU) or
Chinese (CHB and CHS) samples of 1000G project [18]
(http://www.1000genomes.org/) were estimated by compar-
ing risk allele frequency and theWright’s fixation index (𝐹ST)
using plink [19, 20]. Comparison of trait values between cases
and controls was conducted using Student’s 𝑡-test.
3. Results
After rigorous sample and marker level quality control
filtering, genotypes of 28 SNPs on 966 individuals (including
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Table 1: Clinical characteristics of study population.
Traits Controlsa Cases
𝑃 value for
normalized trait
valueb
Samples (𝑁) 469 497
Sex (male/female) 168/301 214/283
Smoking (%) 22.2 31.6
Drinking (%) 38.6 27.2
Age (years) 40.5 ± 15.8 54.3 ± 10.1
BMI (kg/m2) 24.0 ± 4.8 26.1 ± 4.0 <0.001
WC (cm) 81.7 ± 14.5 92.0 ± 11.6 <0.001
TC (mmol/L) 4.6 ± 1.2 5.4 ± 1.2 <0.001
TG (mmol/L) 1.9 ± 1.5 3.1 ± 2.9 <0.001
HDL-C (mmol/L) 1.3 ± 0.3 1.4 ± 1.0 0.775
LDL-C (mmol/L) 2.7 ± 0.9 3.2 ± 1.0 <0.001
aMean ± SD.
bStudent’s 𝑡-test. BMI: body mass index; WC: waist circumference; TC: total
cholesterol; TG: triglyceride; HDL-C: high density lipoprotein cholesterol;
LDL-C: low density lipoprotein cholesterol.
497 with T2D cases and 469 nondiabetic ethnically matched
controls) were kept for subsequent analyses. Clinical char-
acteristics of the sample are summarized in Table 1. Overall,
consistent with previous studies [21], T2D cases in current
study have higher TC, TG, and LDL-C values compared
to controls and have comparable HDL-C values with the
controls, indicating that TC, TG, and LDL-C are among risk
factors for T2D in the Mongolian sample.
Table 2 presents the association results between the 28
SNPs and T2D status. Of the 28 SNPs tested, 11 SNPs were
significantly associated after correcting for multiple testing
(𝑃 < 1.8×10−3).We replicated a T2D association nearKCNQ1
(rs2237897; OR = 1.39; 𝑃 = 0.002), originally identified in
a Japanese population [14], and subsequently replicated in
another Mongolian population sample with the same ethnic
background as our sample [22]. We also replicated T2D
association of three SNPs initially identified in Asian sam-
ples, namely, rs163182 (KCNQ1) [13] in Japanese, rs6723108
(TMEM163) [23] in Indians, and rs10229583 (PAX4) [24]
in Chinese samples. In addition, we replicated associations
of seven T2D SNPs previously identified in European pop-
ulations. To our knowledge, the association of rs7578326
(IRS1), rs1531343 (HMGA2), rs8042680 (PRC1), rs1387153
(MTNR1B), rs7578597 (THADA) [25], rs243021 (BCL11A)
[26], and rs1333051 (CDKN2) [27] was for the first time
replicated in an Asian sample.
Among the four lipid related traits tested, we only
observed a single significant association of T2D risk allele A
of rs7578326 (IRS1) with TG level (𝑃 = 0.0004, OR = 3.4, and
CI 1.7–6.6). Mean TG level for AA, AG, and GG is 2.65,
2.12, and 2.03mmol/L (Figure 1). Individuals homozygous for
the risk allele A have 25% higher TG values compared to
heterozygotes. Heterozygotes have 4% higher TG compared
to those homozygous for the nonrisk allele G.
Most of the SNPs selected for testing in our sample
have been identified to be associated with T2D initially in
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Figure 1: Correlation of mean triglyceride level with the geno-
types of rs7578326 in the Mongolian sample. 𝑦-axis represents
TG (mmol/L) level, and 𝑥-axis represents samples with different
genotypes. Error bar represents standard error of TG in the samples
with the specific rs7578326 genotype. Number of samples with
genotypes GG, AG, and AA are 47, 248, and 647, respectively, across
all samples including T2D cases and controls.
European populations. The lack of replication of 17 T2D
loci identified by the GWAS studies in other populations
prompted us to look at the differences of allelic architecture
in the SNPs tested for the T2D association in our population.
We observed variable risk allele frequency difference between
our sample and 1000G Caucasian (CEU) and Chinese pop-
ulations (Table 3). Six out of 11 SNPs that have risk allele
frequency 10% higher in the Mongolian sample compared
to the Caucasian sample in 1000G panel showed significant
association with T2D in our study, and only two out of nine
SNPs that have 10% or lower risk allele frequency compared
to CEU showed significant association with T2D. Although
statistically not significant, this observation shows a trend of
overabundance of T2D associated SNPs in those with high
frequency of risk alleles in the Mongolian population. In
addition, we calculated Wright’s fixation index to estimate
whether the heterogeneity of a tested SNP is different between
the Mongolian sample and Caucasian or Chinese samples.
Noteworthy, a T2D associated SNP, rs6723108 (TMEM163),
has reached near fixed high risk allele frequency (0.98 in our
sample compared to 0.51 in the Caucasian sample of 1000G
project) and has a substantial population difference with the
Caucasian (𝐹ST as high as 0.61). This trend is also present
for the case of rs8042680 (PRC1), which has much higher
risk allele frequency in the Mongolian sample compared to
the Caucasians (0.92 versus 0.72; 𝐹ST = 0.67). Although it is
difficult to postulate the cause of the population difference,
high proportion ofMongolians appear to carry this risk allele.
4. Discussion
In this study, we chose to examine the association of 34
GWAS SNPs, previously identified in European and East
Asian populations, with susceptibility to T2D in aMongolian
sample from China. Six SNPs did not pass quality control
filtering and were excluded from the analysis.
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Table 2: Association of 28 SNPs tested with T2D in a Mongolian sample.
Chromosome Nearby gene SNP Risk allele Risk allele frequency 𝑃 value OR OR L95a OR H95b
Cases Controls
2 IRS1 rs7578326 A 0.843 0.792 6.4E − 08 1.27 0.98 1.64
12 HMGA2 rs1531343 C 0.111 0.106 6.2E − 07 1.08 0.79 1.49
15 PRC1 rs8042680 A 0.953 0.916 5.6E − 06 1.32 0.86 2.00
2 THADA rs7578597 T 0.989 0.980 8.0E − 06 1.92 0.76 4.76
9 CDKN2 rs1333051 A 0.836 0.833 7.3E − 05 1.05 0.80 1.39
2 TMEM163 rs6723108 T 0.997 0.980 7.9E − 05 7.69 2.00 33.33
11 KCNQ1 rs2237897 C 0.676 0.585 8.7E − 05 1.39 1.11 1.72
11 KCNQ1 rs163182 C 0.427 0.358 1.0E − 04 1.37 1.11 1.69
11 MTNR1B rs1387153 T 0.420 0.358 2.7E − 04 1.17 0.95 1.44
2 BCL11A rs243021 A 0.715 0.696 1.2E − 04 1.33 1.06 1.67
7 PAX4 rs10229583 G 0.848 0.817 4.5E − 04 1.28 0.97 1.69
3 IGF2BP2 rs4402960 T 0.320 0.274 5.0E − 02 1.21 0.97 1.50
2 GRB14 rs3923113 A 0.847 0.812 1.7E − 02 1.20 0.93 1.56
13 SPRY2 rs1359790 G 0.698 0.679 9.9E − 03 1.18 0.95 1.47
3 ADAMTS9 rs4607103 C 0.594 0.566 1.2E − 01 1.11 0.88 1.39
11 KCNJ11 rs5215 C 0.370 0.336 6.1E − 03 1.03 0.84 1.25
10 HHEX-IDE rs5015480 C 0.223 0.219 5.7E − 03 1.01 0.80 1.29
10 TCF7L2 rs7903146 T 0.053 0.061 1.1E − 01 1.01 0.66 1.57
11 CENTD2 rs1552224 A 0.896 0.891 5.3E − 02 1.00 0.72 1.39
15 RASGRP1 rs7403531 T 0.375 0.359 2.5E − 02 0.98 0.80 1.20
4 WFS1 rs1801214 T 0.947 0.943 5.8E − 02 0.98 0.62 1.54
16 FTO rs8050136 A 0.162 0.166 1.3E − 01 0.98 0.75 1.30
8 TP53INP1 rs896854 T 0.351 0.389 3.1E − 02 0.93 0.76 1.15
12 LGR5 rs7961581 C 0.219 0.239 6.1E − 02 0.92 0.72 1.17
10 GRK5 rs10886471 C 0.755 0.774 2.2E − 02 0.86 0.67 1.10
6 C6orf57 rs1048886 G 0.148 0.212 1.2E − 04 0.67 0.51 0.89
15 ZFAND6 rs11634397 G 0.178 0.231 2.6E − 05 0.67 0.52 0.86
5 ZBED3 rs4457053 G 0.055 0.090 1.4E − 02 0.63 0.43 0.94
aLower boundary of 95% confidence interval (CI) of odd’s ratio.
bUpper boundary of 95% CI of odd’s ratio.
This study confirmed the T2D association of rs2237897
in KCNQ1 that were reported in European, Mexican, Chi-
nese, Japanese, and Mongolian populations [8]. We also
replicated the T2D association of three SNPs previously
identified in Asian samples, namely, rs163182 (KCNQ1) [13]
in Japanese, rs6723108 (TMEM163) [23] in Indians, and
rs10229583 (PAX4) [24] in Chinese samples. In addition, our
study replicated T2D association of seven additional GWAS
SNPs in our sample. To our knowledge, the T2D association
of rs7578326 (IRS1), rs1531343 (HMGA2), rs8042680 (PRC1),
rs1387153 (MTNR1B), rs7578597 (THADA) [25], rs243021
(BCL11A) [26], and rs1333051 (CDKN2) [27] was replicated
in an East Asian sample for the first time. This indicates
that our study was able to replicate the result obtained in a
population with the similar ethnic background and extended
the replication of several other loci in an Asian population.
Although the association is not significant after the
multiple test correction, additional six SNPs show the
OR trend consistent with the original reported studies.
SNPs found to be associated with T2D in Asian popula-
tions, rs1048886 (C6orf57) [5], rs4402960 (IGF2BP2) [28],
rs5015480 (HHEX, IDE), rs1359790 (SPRY2) [29], rs1552224
(CENTD2), rs3923113 (GRB14), rs5215 (KCNJ11), rs7903146
(TCF7L2) [6], rs10886471 (GRK5), and rs7403531 (RASGRP1)
[30], were not replicated in our study. This observation
clearly suggests the following: (1) our study has a limited
power because of relatively small sample size, which warrants
further confirmation of these SNPs in a larger sample from
the same ethnic group; (2) our sample has variable degrees
of difference in risk allele frequency compared to Caucasian
population where most original GWAS were conducted, and
(3) the selection of control individuals was not matched
precisely with the cases, in particular, with respect to age,
and there is a trend that the healthy controls are younger
compared to the cases.However, we took a step to use age, sex,
and BMI as covariates in our statistical analysis to minimize
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Table 3: Comparison of risk allele frequency of 28 SNPs tested for association with T2D in a Mongolian sample against 1000G populations.
Nearby gene SNP T2D risk allele T2D risk allele frequency (MGL − CEU)/CEU 𝐹ST with Mongolian sample T2D association
MGLa CEUb CHSc CHBd CEU CHS CHB
TMEM163 rs6723108 T 0.98 0.51 1.00 1.00 0.94 0.66 0.01 0.01 Yes
C6orf57 rs1048886 G 0.21 0.14 0.06 0.10 0.55 0.01 0.07 0.04 No
WFS1 rs1801214 T 0.94 0.65 0.88 0.98 0.46 0.34 0.03 0.01 No
BCL11A rs243021 A 0.70 0.48 0.66 0.63 0.45 0.06 0.23 0.19 Yes
MTNR1B rs1387153 T 0.36 0.25 0.45 0.41 0.42 0.02 0.02 0.00 Yes
GRK5 rs10886471 C 0.77 0.55 0.76 0.79 0.42 0.21 0.00 0.00 No
GRB14 rs3923113 A 0.81 0.59 0.89 0.81 0.37 0.12 0.02 0.00 No
RASGRP1 rs7403531 T 0.36 0.28 0.29 0.34 0.29 0.01 0.01 0.00 No
PRC1 rs8042680 A 0.92 0.72 1.00 1.00 0.28 0.67 0.05 0.04 Yes
IRS1 rs7578326 A 0.79 0.66 0.83 0.86 0.20 0.04 0.00 0.01 Yes
THADA rs7578597 T 0.98 0.88 0.99 1.00 0.12 0.13 0.00 0.00 Yes
PAX4 rs10229583 G 0.82 0.75 0.84 0.84 0.09 0.01 0.00 0.00 Yes
CENTD2 rs1552224 A 0.89 0.88 0.91 0.90 0.01 0.00 0.00 0.00 No
HMGA2 rs1531343 C 0.11 0.11 0.12 0.11 0.00 0.00 0.00 0.00 Yes
CDKN2 rs1333051 A 0.83 0.84 0.88 0.86 −0.01 0.00 0.00 0.00 Yes
SPRY2 rs1359790 G 0.68 0.73 0.70 0.67 −0.07 0.00 0.00 0.00 No
LGR5 rs7961581 C 0.24 0.26 0.21 0.19 −0.09 0.00 0.00 0.00 No
TP53INP1 rs896854 T 0.39 0.43 0.30 0.31 −0.09 0.00 0.02 0.01 No
IGF2BP2 rs4402960 T 0.27 0.31 0.23 0.25 −0.11 0.00 0.00 0.00 No
KCNJ11 rs5215 C 0.34 0.38 0.40 0.38 −0.12 0.00 0.00 0.00 No
KCNQ1 rs163182 C 0.36 0.41 0.31 0.39 −0.13 0.00 0.00 0.00 Yes
ADAMTS9 rs4607103 C 0.57 0.78 0.64 0.57 −0.28 0.09 0.01 0.00 No
ZFAND6 rs11634397 G 0.23 0.34 0.07 0.08 −0.33 0.33 0.07 0.06 No
KCNQ1 rs2237897 C 0.58 0.94 0.66 0.62 −0.38 0.23 0.01 0.00 Yes
FTO rs8050136 A 0.17 0.44 0.14 0.15 −0.63 0.19 0.00 0.00 No
ZBED3 rs4457053 G 0.09 0.30 0.04 0.07 −0.70 0.17 0.01 0.00 No
TCF7L2 rs7903146 T 0.06 0.31 0.03 0.02 −0.81 0.27 0.01 0.01 No
aMongolian sample of this study. b,c,dPopulation samples of Caucasian, Chinese in Beijing, and Chinese in Shanghai from the 1000G project, respectively.
the effect of this disparity. The follow-up larger scale study
should recruit more matching control individuals to cases.
None of the SNPs we tested for association with
T2D here has been previously implicated to be associated
with lipids based on the NHGRI GWAS catalog (available
at http://www.genome.gov/gwastudies/, November, 2012).
However, we observed that association of T2D risk allele
(A, major allele) of rs7578326 (IRS1) is associated with the
increased level of TG. An elevated level of TG has been
implicated as a risk factor of T2D, which likely resulted
from the diminished activity of insulin causing inhibition
of microsomal TG transfer protein activity [31]. The major
allele (A) of a SNP in the upstream region of the same gene
(IRS1), namely, rs2972146, is reported to be associated with
an elevated level of TG as well [32]. rs297214 has nominal
linkage disequilibrium with the SNP reported here (𝑟2 =
0.3753, 1000G phase I), indicating a possibility that the
T2D associated SNP or its proxy could be playing a role in
pathogenesis of T2D or its related TG metabolism through
IRS1 activity. Further functional work will help to understand
the role of this SNP. Since we did not have information
on previous medical history of treatment for either high
cholesterol or T2D for the patients, it is possible that such
treatments, if administered previously, could have prevented
us from seeing the effect of SNP association with the diabetes
related quantitative traits, including TG.
Mongolians are one of the people who reside on the
Mongolian Plateau in Asia and have heavily depended on
nomadic life styles with harsh environments characterized
by low temperature and scarce availability of food sources
[33]. Although we do not have any concrete evidence that
these variants might play a role in conserving energy, we
found six T2D associated SNPs in our sample that have
10% or higher risk allele frequency compared to Caucasian
samples. These SNPs have a comparable risk allele frequency
with Chinese populations in the 1000G project, indicating
that our allele frequency estimate is reflecting the allelic
structure of the SNPs in the populations of Asia.We observed
that SNPs rs6723108 (TMEM163) and rs8042680 (PRC1)
have substantial allelic differences in our sample compared
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to Caucasians and the risk alleles have reached near fixed
level in Mongolians. On the other hand, a widely replicated
T2D SNP, rs7903146 (TCF7L2), in European populations
has substantially low risk allele frequency in the Mongolian
sample (0.06 versus 0.31 in the Caucasian sample; 𝐹ST = 0.27)
and is not associated in our sample of modest size. It is
likely that the frequency difference of some SNPs between our
sample and European population also contributed to the lack
of reproducibility in T2D association in our study.
Although we note that rs6723108 has a wide range of OR
estimate (95%CI 2–33.3; risk allele frequency 0.98), theOR of
7.7 in our study is substantially greater thanwhatwas reported
in the original study in an Indian population [23] (OR = 1.31,
95% CI 1.20–1.44; risk allele frequency 0.89), indicating the
potential higher effect of the variant in our sample. More
systematic studies of population specific allelic architecture
with respect to T2D are needed to dissect the potential impact
of these highly differentiated SNPs in different populations.
In conclusion, our association study has confirmed asso-
ciation of several previously identified T2D susceptibility loci
in the Mongolian sample. We also identified rs7578326 near
IRS1 to be associated with an increased level of TG. The
observation of the remarkable allele frequency difference of
the T2D SNPs in our sample compared to Caucasians is
important in further identifying causative variants for T2D
and understanding the role of these SNPs in development of
T2D in different ethnic populations.
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